View in EDS HTML Full Text PDF Full Text

Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury.

Saved in:

Bibliographic Details
Title:	Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury.
Authors:	Niu, Chao¹ (AUTHOR) 19937671631@163.com, Dong, Daoquan¹ (AUTHOR), Cui, Longjiang¹ (AUTHOR), Dong, Yingli¹ (AUTHOR), Wang, Wei² (AUTHOR)
Source:	Diabetology & Metabolic Syndrome. 6/18/2025, Vol. 17 Issue 1, p1-13. 13p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17585996
DOI:	10.1186/s13098-025-01804-7